A phase 1 open-label study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide alone or combined with an aromatase inhibitor in women with advanced breast cancer Meeting Abstract
| Authors: | Traina, T. A.; Yardley, D. A.; Patel, M. R.; Schwartzberg, L. S.; Elias, A.; Gucalp, A.; Blaney, M. E.; Gibbons, J.; Hudis, C. A.; LoRusso, P. |
| Abstract Title: | A phase 1 open-label study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide alone or combined with an aromatase inhibitor in women with advanced breast cancer |
| Meeting Title: | 6th IMPAKT Breast Cancer Conference |
| Journal Title: | Annals of Oncology |
| Volume: | 25 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 May 8-10 |
| Meeting Location: | Brussels, Belgium |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2014-05-01 |
| Start Page: | i4 |
| Language: | English |
| ACCESSION: | WOS:000336094500005 |
| DOI: | 10.1093/annonc/mdu064.1 |
| PROVIDER: | wos |
| PUBMED: | 24764359 |
| Notes: | Meeting Abstract: 10P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
